The cancer pain is an important factor affecting life quality of patients with cancer. It has a complex mechanism,The key of treatment is based on the cancer painful etiology which involved chemotherapy, radiotherapy,surgery, analgetic drug, traditional Chinese medicine and remedies, cognitive psychology and so on. Effective treatments may alleviate the cancer pain, and improve the quality of life of patients. It is an impor-tant measure of alleviating cancer pain to select an individual therapeutic schedule and combine an evaluation of cancer pain from clinicians.

Multiple myeloma (MM) is a malignant hematologic disorder.The early diagnosis,accurate staging and timely therapeutic evaluation have great impact on the treatment planning,disease monitoring and prognosis.Although X-ray examination is the standard staging modality for MM,18F-FDG PET/CT has been proved additionally valuable for diagnosis,outcome prediction of MM.This article is to update the clinical role of 18F-FDG PET in the evaluation of MM.The application of other PET radiopharmaceuticals including 11 C-MET,11 C-acetate,11 C-choline and 18 F-FLT are also reviewed.

Objective: The FDA regulation requirements for medical device software are relatively mature and systematic, and the research on the FDA regulation thinking of medical device software helps to promote the regulation work of the medical device software in our country. Methods:Based on the comparison of the 1998 edition and 2005 edition FDA software submission guidance, the trend of the FDA regulation requirements for medical device software was analyzed, and then its regulation thinking was discussed according to other current effective software-related guidance. Results:FDA integrally improves the submission requirements for all medical device software, especially for the minor Level of Concern software, and simplifies the requirements for design specification, verification and validation, but strengthens the requirements for traceability analysis and revision history. Conclusion: The regulation work of the medical device software in our country needs to fully consider the particularity of the medical device software, strengthen the audit of software quality management system, implement the software traceability analysis, and determine the regulation requirements for software change.

Gap junctions are specialized transmembrane channels that enable the direct exchange of materials and transfer chemical or electrical signaling between adjacent cells, thus maintaining cellular homeostasis. In the nervous system, gap junction chan-nels not only mediate intercellular coupling between neurons and between glial cells, but also can be involved in secondary dam-age under pathological conditions. Recently, some studies have shown that gap junctions play an important role in neuropathic pain caused by nervous system damage. Research on the role of gap junctions in neuropathic pain can contribute to a deeper un-derstanding of the pathogenesis of neuropathic pain, providing a new research direction for the treatment of neuropathic pain.

Objective To understand drug resistance in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS)after antiretroviral therapy(ART).Methods Articles about drug resistance in HIV/AIDS patients after ART were retrieved from Wangfang data,China National Knowledge Infrastructure(CNKI),and PubMed. Meta analysis were performed.Results 15 articles (1 English and 14 Chinese) were extracted,quality score of 3,4,and 8 articles was 6,7,and 8 respectively. Heterogeneity of the included stud-ies showed the difference was significant (Q= 45.98,P<0.001),there was heterogeneity,random-effects models was conducted for Meta analysis,which revealed that the overall drug resistance rate in HIV/AIDS patients in China was 4% (4% -5% );Begg's test showed that P= 0.012,there was publication bias. After articles were excluded through sensitivity analysis,the combined effect was still 4% (4% -5% ).Conclusion The overall drug resistance rate in Chinese HIV/AIDS patients after ART is not high.

Objective:To discuss the regulation requirements of software based on the analysis of software-related recalls of medical devices. Methods:The data of software-related recalls of medical devices in America were collected and processed, and the type, situation, cause and trend of software-related recalls were analyzed, then the suggestions on the regulation requirements of software were proposed. Results:During the four periods from 1983 to 2011, the percentage of software-related recalls vs medical device recalls in America increased from 6%to 19%, and the year-on-year growth rate of software-related recalls rose by 47%to 164%, significantly higher than medical device recalls in the same period (from 13%to 54%). Especially, the problem of software-related recalls in radiology medical devices was the most serious. Conclusion: The regulatory situation of software is more complicated and severe, so the regulation requirements of software, including software validation, adverse event monitoring and usability design, need to be further strengthened according to the particularity of software.

Objective To analyze the reason of nursing complaints and discuss prevention measures. Methods From October 2007 to October 2011,52 cases nursing complaints were retrospectively analyzed in my hospital.The countermeasures were summarized. Results The reasons of nursing complaints were the cost issue,no strong responsibility,bad service attitude and insufficient communication and so on.All complaints were taken service recovery and improvement measures,and 52 cases nursing complaints were resolved through effective communication. Conclusions Strengthening occupational ethics education and legal knowledge learning,improving the service attitude,mastering the communication skills,improving the level of business,strengthening management can improve the nurse-patient relationship and reduce nursing complaints.

BACKGROUND:Three-dimensional self-assembling peptide nanofiber hydrogel scaffold can simulate the in vivo microenvironment and provide a structural model for cells, which promotes the right composition of extracel ular matrix and cel growth, as wel as improves the cel functions. OBJECTIVE:To review the fundamental research and the experimental study of the self-assembling peptide nanofiber scaffold in the nerve tissue engineering. METHODS:Literatures concerning basic and experimental studies on the self-assembling peptide nanofiber scaffold in the nerve tissue engineering were reviewed via searching PubMed and VIP databases (2000/2013) using the key words of“self-assembling peptide, nanofiber scaffold, RADA16, nerve tissue engineering, neural stem cel . RESULTS AND CONCLUSION:Self-assembling peptide nanofiber scaffold is a novel and ideal tissue engineering material which provides new method for nerve injury repairing, for it not only solves the problem of poor compatibility between the material and cells, but also plays a much more pivotal role in maintaining three-dimensional properties, promoting cel activities and mimicking the extracel ular matrix, which is superior to other materials. However, there stil exist some chal enges in the area of self-assembling peptides, including short-term issues such as integrating of self-assembling peptide with bio-macromolecular material or relatively developed traditional transplant;and long-term issues such as adapting immune system in vivo, treating targets within cells and anticipating the future fate of highly integrated scaffolds.

The importance of software version in the medical device software supervision does not cause enough attention at present. First of all, the effect of software version in the medical device software supervision is discussed, and then the necessity of software version in the medical device software supervision is analyzed based on the discussion of the misunderstanding of software version. Finally the concrete suggestions on software version naming rules, software version supervision for the software in medical devices, and software version supervision scheme are proposed.
Equipment and Supplies ; Software

AlM: To comprehensively evaluate of visual quality after epipolis laser in situ keratomileusis ( EPl-LASlK) in mild to moderate myopia.METHODS: Sixty cases ( 120 eyes ) undergone EPl-LASlK with equivalent diopter ( SE ) were divided into two groups:mild myopia group (60 eyes) and moderate myopia group ( 60 eyes ) . Objective visual acuity, aberration, contrast sensitivity and glare sensitivity were measured before and 1wk; 1, 6mo after operation, and made comparative analysis. RESULTS: Postoperative uncorrected visual acuity ( UCVA ) of two groups were better than that of preoperative(P<0. 05). Postoperative 6mo, there were significant differences on total high RMS between two groups ( P < 0. 05 ). Before operation and 6mo after operation, higher - order aberrations had statistically significant difference between two groups (P<0. 05). After 1wk and 1mo, there were statistical significances at the five frequencies between two groups (P<0. 05). After 6mo, the mild myopia group returned to preoperative levels, however, moderate myopia group in the high frequency region ( 18. 0c/d ) had significant difference with before surgery (P<0. 05). 1wk after surgery, there were statistically significant differences on the 3. 0, 6. 0, 12.0, 18. 0c/d frequency in both groups (all P<0. 05), 1mo after surgery, there were significant difference at 12.0, 18.0c/d frequencies (all P<0.05), after 6mo, both groups returned to preoperative levels, showed no significant difference.CONCLUSlON:Visual quality is poorer in mild myopia patients than that in moderate myopia at early stage after EPl-LASlK. Better visual quality is observed at mid-late stage.